US Activist Hedge Fund Institutional SEC 13D 13G — August 20, 2026

Activist & Institutional Activity

By Gunpowder Editorial ·

20 high priority 28 medium priority 48 total filings analysed

Executive Summary

This digest of 48 activist and institutional filings reveals a market characterized by significant insider conviction in micro-cap turnaround situations, particularly in the biotechnology and specialty finance sectors, alongside notable institutional accumulation in large-cap value names like Republic Services.

A key theme is the emergence of activist-like engagement from previously passive investors, such as Conifer Management's switch to a 13D for Group 1 Automotive, signaling a more active stance. Insider buying at Hepion Pharmaceuticals and the strategic accumulation by Christian Angermayer's group in Enhanced Group Inc. point to high-conviction bets on distressed assets. Conversely, the digest highlights a wave of insider selling and exit filings, including the dissolution of the Brera Holdings group and the reduction of stakes in Cimpress and Tredegar, suggesting a rotation out of certain positions. The data also reveals a cluster of passive institutional stakes in small-cap and micro-cap companies, indicating a search for alpha in less efficient markets. Overall, the period-over-period comparisons and insider activity patterns suggest a bifurcated market where insiders are aggressively backing their own turnarounds while reducing exposure to others, creating both high-risk and high-opportunity scenarios.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Schedule 13D · Schedule 13G

Tracking the trend? Catch up on the prior US Activist Hedge Fund Institutional SEC 13D 13G digest from August 13, 2026.

Investment Signals (11)

  • Republic Services (RSG) (BULLISH)

    Cascade Investment (Bill Gates) purchased 1.6M shares ($340M-$358M) in open market over 60 days, increasing stake to 36.7%. This is a massive vote of confidence from a long-term, highly sophisticated investor, signaling deep value at ~$213-$224/share.

  • Group 1 Automotive (GPI) (BULLISH)

    Conifer Management switched from 13G to 13D, disclosing a 9.7% stake and amicable discussions to place an affiliate on the board. This signals a potential activist catalyst for operational improvements or strategic alternatives.

  • Hepion Pharmaceuticals (HEPA) (BULLISH)

    Executive Chairman, COO, and interim CEO collectively purchased $900K in stock and warrants at $0.06/share in recent months, now owning 37.6% of the company. This is extreme insider conviction in a micro-cap biotech, suggesting a potential near-term catalyst.

  • Marriott Vacations Worldwide (VAC)

    Impactive Capital sold 750,000 shares (2.2% of shares outstanding) at $111.49, citing portfolio rebalancing. While the sale is large, the explicit statement that it's not a negative view on the company's prospects is a signal to watch for a potential overhang removal. [NEUTRAL/BULLISH]

  • Spruce House sold 200,000 shares, dropping below the 5% threshold. The sale at ~$90/share by a former activist investor could signal a lack of confidence in near-term value realization or a shift in strategy.

  • Enhanced Group Inc. (fka AParadise Acquisition Corp.) (BULLISH)

    Christian Angermayer's group purchased 2.1M shares for $3.56M, increasing stake to 31.5%. This continued accumulation by a prominent biotech/life sciences investor signals high conviction in the post-merger entity.

  • GoPro (GPRO) (BULLISH)

    Mark Edward Fischbach (a prominent individual) disclosed a new 8.5% stake (13.5M shares) acquired on July 13, 2026. This is a significant passive stake from a non-institutional investor, potentially signaling a belief in a brand turnaround or asset value.

  • Viridian Therapeutics (VRDN) (BULLISH)

    Point72 Asset Management disclosed a new 5.0% stake (5.7M shares). A new position from a top-tier quant/fundamental firm signals a data-driven positive view on the company's pipeline or valuation.

  • The Gottwald family trust sold shares on the NYSE in the past 60 days, reducing its stake to 3.1%. This is a direct insider sale from a family that has held the stock for decades, a potentially bearish signal for the company's near-term prospects.

  • Axil Brands (AXIL) (BULLISH)

    Insider Jeff Toghraie and affiliates control 46.9% of the company. The high concentration of ownership and an expiring Voting Agreement (Oct 17, 2026) creates a potential catalyst for a control transaction or strategic change.

  • Phoenix Financial Ltd. reduced its stake to just below 5% (4.98%). This is a classic 'shadow selling' pattern where a large holder reduces without triggering market alarm, but it represents persistent selling pressure.

Risk Flags (9)

  • Hepion Pharmaceuticals (HEPA) [HIGH RISK]

    While insider buying is extreme, the company is a micro-cap biotech with no revenue. The $0.06/share price and massive dilution (26M+ shares to insiders) signal a distressed capital structure. The risk of total capital loss is very high.

  • Activist investor Spruce House sold its entire stake, dropping below 5%. This is a clear vote of no confidence from a sophisticated investor, creating a negative overhang and removing a potential catalyst for change.

  • The Gottwald family, which has controlled the company for decades, is selling shares. This is a major red flag for long-term holders, suggesting a lack of confidence in the company's strategic direction or future value.

  • The entire Schedule 13D group disbanded, and all members now own less than 5%. This is a complete exodus of a coordinated investor group, signaling a total loss of confidence in the company's prospects.

  • A major 12.75% shareholder (Pau Hung To) transferred all his shares to satisfy personal debts, reducing his stake to 0%. This is a distressed sale by a key insider, a very negative signal.

  • 22nd Century Group (XXII) [HIGH RISK]

    Two separate filers (Joseph Reda and Jonathan Schechter) each reported 9.97% and 9.9% stakes, respectively. The near-identical ownership percentages and the company's distressed nature (micro-cap, 714K shares outstanding) suggest a highly volatile and potentially manipulated stock.

  • A director exercised warrants for a 35.67% stake at a nominal price ($0.00001/share). The waiver of the beneficial ownership limitation and 61-day waiting period is a red flag for extreme dilution and potential control issues.

  • Elastic N.V. (ESTC) [MEDIUM RISK]

    Pictet Asset Management, while filing as passive, explicitly reserves the right to seek influence through board engagement. This 'mild activist uncertainty' creates an overhang and potential for disruptive conflict.

  • 4.5M warrants held by a major shareholder (Steele ExpCo) expired unexercised. This is a direct signal that a sophisticated investor chose not to invest further capital, implying a negative view on the company's valuation or prospects.

Opportunities (9)

  • Republic Services (RSG) (OPPORTUNITY)

    Bill Gates' Cascade Investment is aggressively accumulating at $213-$224, a strong signal of long-term value. The stock is a high-quality defensive name with a powerful insider buyer.

  • Group 1 Automotive (GPI) (OPPORTUNITY)

    Conifer Management's switch to 13D and board discussions create a classic activist catalyst. The 9.7% stake provides significant leverage to push for operational improvements, asset sales, or a sale of the company.

  • Hepion Pharmaceuticals (HEPA) (OPPORTUNITY)

    The extreme insider buying at $0.06/share by the entire C-suite and board creates a high-risk/high-reward opportunity. If the company has a near-term catalyst (e.g., a financing, partnership, or pipeline update), the stock could re-rate significantly.

  • Enhanced Group Inc. (ENH) (OPPORTUNITY)

    Christian Angermayer's continued accumulation (now 31.5%) in a post-SPAC entity signals strong conviction. The purchase of 2.1M shares for $3.56M in three days is a powerful near-term demand signal.

  • GoPro (GPRO) (OPPORTUNITY)

    A new 8.5% stake from a non-institutional investor (Mark Fischbach) is a unique catalyst. It could signal a potential brand collaboration, a marketing partnership, or a belief that the brand's value is not reflected in the stock price.

  • Viridian Therapeutics (VRDN) (OPPORTUNITY)

    Point72's new 5% stake is a strong quantitative/fundamental buy signal. For a biotech, this can be a leading indicator of positive data or a potential M&A target.

  • Axil Brands (AXIL) (OPPORTUNITY)

    The expiring Voting Agreement (Oct 17, 2026) and 46.9% insider control create a forced catalyst. The insiders must decide on a new agreement, a sale, or a restructuring, which could unlock significant value.

  • Black Stone Minerals (BSM) (OPPORTUNITY)

    Morgan Stanley disclosed a new 5.2% passive stake. For a high-yield MLP, a new position from a major bank signals a positive view on the distribution sustainability and underlying commodity price outlook.

  • North Peak Capital Management disclosed a new 6.2% passive stake. This is a vote of confidence in a small-cap company from a specialized investment firm, often a precursor to more active engagement or a take-private.

Sector Themes (6)

  • Insider Conviction in Micro-Cap Biotech

    The filings for Hepion Pharmaceuticals (HEPA) show a coordinated and massive insider purchase by the entire executive team and board. This is a powerful signal of a potential turnaround or near-term catalyst, contrasting with the broader market's risk-off sentiment. Implication: Investors should scrutinize other micro-cap biotechs for similar insider buying patterns.

  • Passive Accumulation in Large-Cap Value

    Cascade Investment's continued buying of Republic Services (RSG) and Morgan Stanley's new stake in Black Stone Minerals (BSM) highlight a trend of institutional capital flowing into defensive, high-quality, large-cap value names. Implication: This suggests a preference for stability and cash flow generation over growth in the current environment.

  • Activist Pivot from Passive

    Conifer Management's switch from a 13G to a 13D for Group 1 Automotive (GPI) is a clear example of a previously passive investor taking a more active stance. This could be a leading indicator for other similar filings where large holders are becoming dissatisfied with management. Implication: Monitor for other 13G filers who have the size and incentive to become activists.

  • Exit and Dissolution Patterns

    The digest shows multiple instances of investor groups dissolving (Brera Holdings) or major holders selling down (Cimpress, Tredegar, Advanced Biomed). This suggests a broad-based de-risking or rotation out of specific sectors or small-cap names. Implication: This creates a negative technical overhang for these stocks but also presents potential entry points if the selling is overdone.

  • Concentrated Insider Ownership in Micro-Caps

    Multiple filings (Axil Brands, Dogness, Hepion, Addentax) show insiders holding 30%+ of the company. This extreme concentration creates a high-stakes environment where insider actions (buying/selling) are extremely informative. Implication: These stocks are binary bets on the insiders' ability to execute, making their filings the most important data point.

  • Institutional Interest in Post-SPAC Entities

    Christian Angermayer's continued accumulation in Enhanced Group Inc. (ENH) and Linden Capital's new stake in Thunder Bridge Capital Partners V (a SPAC) suggest that sophisticated investors are finding value in the post-SPAC landscape, likely due to depressed valuations and forced selling. Implication: This could be a contrarian opportunity in high-quality de-SPACed companies.

Watch List (8)

  • Axil Brands (AXIL)
    👁

    The Voting Agreement expires on October 17, 2026. Watch for a new agreement, a tender offer, or a going-private transaction as the deadline approaches.

  • Group 1 Automotive (GPI)
    👁

    Conifer Management is in discussions to place an affiliate on the board. Watch for an official director nomination or a public letter outlining strategic demands.

  • Hepion Pharmaceuticals (HEPA)
    👁

    With the entire C-suite and board now owning 37.6% of the company, watch for a press release announcing a strategic partnership, a financing, or a pipeline update to justify the insider buying.

  • Marriott Vacations Worldwide (VAC)
    👁

    Impactive Capital's 750,000 share sale creates an overhang. Watch for any further sales or, conversely, a new 13D filing if they decide to re-engage more aggressively.

  • With Spruce House exiting, watch for any new activist to step in or for the company to announce a new strategic plan to address the valuation gap.

  • Pictet Asset Management's 'mild activist' stance is a developing situation. Watch for any 13D/A amendments that detail specific demands or board-level discussions.

  • Republic Services (RSG)
    👁

    Cascade Investment has been a consistent buyer. Watch for any acceleration in purchases or a potential tender offer if the stock price declines.

  • Enhanced Group Inc. (ENH)
    👁

    Christian Angermayer's group now owns 31.5%. Watch for a potential going-private offer or a major business combination announcement.

Filing Analyses (48)
Axil Brands, Inc. SC 13D/A neutral materiality 6/10

20-08-2026

Jeff Toghraie, Intrepid Global Advisors, Inc., and Don Frank Nathaniel Vasquez filed Amendment No. 8 to their Schedule 13D for Axil Brands, Inc. (AXIL) on August 20, 2026, reflecting updated beneficial ownership percentages due to a change in the company's outstanding shares. Toghraie beneficially owns approximately 46.9% of the common stock, Intrepid owns 43.4%, and Vasquez owns 18.7%, with voting and dispositive powers allocated among them via a Voting Agreement expiring October 17, 2026.

  • · The filing is an amendment to Schedule 13D originally filed September 9, 2022.
  • · Toghraie's options include 155,000 shares at $1.80 expiring April 20, 2032 (fully vested) and 350,000 shares at $4.01 expiring October 31, 2034 (vesting monthly over 48 months).
  • · Preferred Stock held by Intrepid is convertible into Common Stock on a twenty-for-one basis, subject to a 5% beneficial ownership cap.
  • · The Voting Agreement between Intrepid and Vasquez expires on the earlier of October 17, 2026, a written notice from Intrepid, or mutual written agreement.
  • · Outstanding shares used for percentage calculations: 6,822,681 as of August 14, 2026.
REPUBLIC SERVICES, INC. SC 13D/A neutral materiality 6/10

20-08-2026

Cascade Investment, L.L.C., the investment vehicle of William H. Gates III, filed an amended Schedule 13D disclosing beneficial ownership of 112,403,625 shares of Republic Services, Inc. common stock, representing 36.7% of the 306,212,978 shares outstanding as of July 30, 2026. During the 60-day period ended August 19, 2026, Cascade purchased an additional 1,599,643 shares in open-market transactions at weighted-average prices ranging from approximately $213.00 to $224.09 per share. The filing indicates continued accumulation by a major long-term shareholder, though the overall ownership percentage and strategic intent remain unchanged.

  • · Cascade purchased 1,599,643 shares during the 60-day period ended August 19, 2026 in open-market transactions.
  • · The weighted-average purchase price per share ranged from $213.00 to $224.09 across various transaction dates.
  • · The filing is Amendment No. 28 to the original Schedule 13D filed on July 21, 2008.
  • · All shares are held by Cascade; Gates is deemed beneficial owner as sole member of Cascade.
  • · The filing does not disclose any change in purpose or plans for the Issuer.
REDWOOD TRUST INC SC 13G neutral materiality 3/10

20-08-2026

Bay Pond Investors (Bermuda) L.P. reported a 5.08% beneficial ownership stake in Redwood Trust Inc., holding 6,379,415 common shares as of August 14, 2026, under Rule 13d-1(c) of the Securities Exchange Act of 1934. The filing is a passive investment disclosure (Schedule 13G) and does not indicate any intent to change or influence control of the issuer. No period-over-period comparisons are available as this is a single reporting event.

  • · Beneficial ownership reported under Rule 13d-1(c) (passive investor, no control intent).
  • · Filing date: August 20, 2026; event date: August 14, 2026.
  • · Issuer's fiscal year end: December 31; filer's fiscal year end: June 30.
  • · No dispositive power is retained by the filer—shared voting and dispositive power with limited partners.
AParadise Acquisition Corp. SC 13D/A positive materiality 8/10

20-08-2026

Apeiron Investment Group Ltd. and related entities filed Amendment No. 3 to Schedule 13D, disclosing a 31.5% beneficial ownership stake in Enhanced Group Inc. (formerly AParadise Acquisition Corp.). Between August 17-19, 2026, the group purchased 2,117,316 Class A shares for $3.56M, and on August 14, 2026, a second tranche of a Purchase Agreement closed, delivering 2,120,823 shares and warrants. The filing reflects continued accumulation by Christian Angermayer's group, with no disposals or negative performance metrics reported.

  • · The filing is Amendment No. 3 to Schedule 13D, originally filed May 14, 2026.
  • · The ownership percentage is based on 128,972,162 Class A shares outstanding as of Aug 13, 2026, per the Issuer's Prospectus Supplement filed Aug 17, 2026.
  • · The reporting persons disclaim beneficial ownership of 258,837,933 Class B shares held.
  • · Christian Angermayer disclaims beneficial ownership of the securities reported.
  • · No transactions in Class A Common Stock were effected since Amendment No. 2, except those described in Items 3 and 4.
MapLight Therapeutics, Inc. SC 13G neutral materiality 5/10

20-08-2026

MapLight Therapeutics, Inc. (MPLT) disclosed in a Schedule 13G filing that a group of affiliated entities, including Pivotal bioVenture Partners Fund II, L.P., NFLS Beta Limited, and Permwell Management Limited, collectively beneficially own 2,915,874 shares of common stock, representing 5.5% of the company's outstanding voting shares as of August 13, 2026. The filing indicates that the shares are held for investment purposes and not with the intent to change or influence control of the issuer. The ownership percentage is based on 52,848,208 shares outstanding, which includes shares issued in a recent private placement.

  • · The reporting persons include a chain of entities ultimately controlled by Nan Fung Group Holdings Limited, with Pivotal II directly holding 611,446 shares, NFLS Beta directly holding 671,606 shares, and Permwell directly holding 1,628,722 shares.
  • · The ownership percentage is based on 52,848,208 shares outstanding, which includes 43,650,321 shares as of August 7, 2026 and 9,197,887 shares issued in a private placement reported on Form 8-K.
  • · The filing is made pursuant to Rule 13d-1(c), indicating passive investment intent.
  • · The reporting persons disclaim beneficial ownership of 3,500 shares held by Mr. Bisgaard and 600 shares held by Mr. Hopfner.
  • · The group's aggregate ownership of 5.5% is unchanged from the prior reporting period, indicating no material change in stake.
TREDEGAR CORP SC 13D/A neutral materiality 5/10

20-08-2026

Amendment No. 19 to Schedule 13D filed by the Gottwald family and related trust discloses their aggregate beneficial ownership of 5,987,852 shares (17.1%) of Tredegar Corporation. The filing reports recent sales of shares by the Residual 10-Year CLAT UA FDGJR Living Trust on the NYSE in the past sixty days, reducing its stake to 3.1%. The reporting persons retain significant voting and dispositive power over the shares.

  • · The filing is Amendment No. 19 to the Schedule 13D initially filed on August 15, 1989.
  • · The CLAT sold shares on the NYSE in the past sixty days, as detailed in Exhibit 99.2.
  • · Sole voting power: John D. Gottwald 1,917,639 shares (5.5%), William M. Gottwald 211,260 shares (0.6%), James T. Gottwald 40,000 shares (0.1%), all reporting persons 2,168,899 shares (6.2%).
  • · Shared voting power: John D. Gottwald 3,718,170 shares (10.6%), William M. Gottwald 3,728,953 shares (10.7%), James T. Gottwald 3,818,953 shares (10.9%), CLAT 1,085,761 shares (3.1%), all reporting persons 3,818,953 shares (10.9%).
  • · Sole dispositive power: John D. Gottwald 1,917,639 shares (5.5%), William M. Gottwald 211,260 shares (0.6%), James T. Gottwald 40,000 shares (0.1%), all reporting persons 2,168,899 shares (6.2%).
  • · Shared dispositive power: John D. Gottwald 3,718,170 shares (10.6%), William M. Gottwald 3,728,953 shares (10.7%), James T. Gottwald 3,818,953 shares (10.9%), CLAT 1,085,761 shares (3.1%), all reporting persons 3,818,953 shares (10.9%).
  • · The percentage ownership is based on 34,944,164 shares outstanding as reported in the Form 10-Q for the quarter ended June 30, 2026.
GAXOS.AI INC. SC 13G neutral materiality 6/10

20-08-2026

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G disclosing beneficial ownership of 722,280 shares of GAXOS.AI INC. common stock, representing 4.99% of the outstanding shares as of August 20, 2026. This follows an inducement letter agreement on August 14, 2026, under which the Reporting Persons could have been deemed to own up to 7.2% of the company (including warrants), but a blocker provision limits their beneficial ownership to 4.99%. The filing indicates a significant but capped stake, with the securities held for investment purposes and not to influence control.

  • · The Schedule 13G is filed under Rule 13d-1(c), indicating the securities are not held to change or influence control.
  • · The New Intracoastal Warrant includes a blocker provision preventing exercise that would result in beneficial ownership exceeding 4.99%.
  • · Without the blocker provision, the Reporting Persons could have been deemed to own 1,678,456 shares (11.6% of the then-outstanding shares).
  • · The filing was made jointly by all three Reporting Persons via a Joint Filing Agreement.
Viewbix Inc. SC 13G/A neutral materiality 3/10

20-08-2026

Daniel Nissim and J.B.D Innovation Ltd. filed a Schedule 13G/A disclosing aggregate beneficial ownership of 7.61% of Quantum X Labs Inc. (formerly Viewbix Inc.) common stock as of June 30, 2026. The filing reflects a decrease from the prior 13G filing, as Nissim's direct holdings dropped from 394,554 shares to 350,271 shares, while J.B.D Innovation Ltd. reported 1,350,000 shares (5.90%) including exercisable options and warrants. The filing is a routine beneficial ownership update with no change in control intent.

  • · Daniel Nissim directly holds 350,271 shares and has a pre-funded warrant for 44,283 shares (with a 4.99% blocker provision).
  • · J.B.D Innovation Ltd. holds 300,000 shares directly, plus options for 750,000 shares and a warrant for 300,000 shares (also with a 4.99% blocker provision).
  • · The filing is an amendment (13G/A) and the prior 13G showed higher direct holdings for Nissim (394,554 shares).
  • · The company changed its name from Viewbix Inc. to Quantum X Labs Inc. on August 7, 2019.
Viridian Therapeutics, Inc.\DE SC 13G neutral materiality 3/10

20-08-2026

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 5,687,507 shares of Viridian Therapeutics, Inc. common stock, representing 5.0% of the company's outstanding shares as of August 19, 2026. The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

  • · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
  • · Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen each directly own no shares; all shares are held by Point72 Associates, LLC.
  • · Cubist Systematic Strategies, LLC acts as a sub-advisor with respect to a portion of the shares.
  • · The beneficial ownership is as of the close of business on August 19, 2026.
  • · The filing includes a Joint Filing Agreement among the reporting persons.
GROUP 1 AUTOMOTIVE INC SC 13D mixed materiality 8/10

20-08-2026

Conifer Management, L.L.C. filed a Schedule 13D disclosing beneficial ownership of 1,157,100 shares of Group 1 Automotive Inc. common stock, representing approximately 9.7% of the outstanding shares. The firm, which has been a supportive long-term investor, has recently engaged in amicable discussions with the issuer about the possibility of an affiliate employee, Benjamin Hart, joining the board of directors. The switch from Schedule 13G to 13D signals a more active stance, including potential further purchases, sales, or strategic engagement, though no specific timeline or outcome is guaranteed.

  • · Conifer Management acquired all shares for investment purposes in the ordinary course of business.
  • · The reporting person has sole voting and dispositive power over all 1,157,100 shares.
  • · No criminal convictions or civil securities-related proceedings against Conifer or Gregory Alexander in the past five years.
  • · Conifer may use margin account borrowings; no specific margin amount is identifiable.
  • · Recent open-market purchases by Conifer funds between June 25 and August 4, 2026, at prices ranging from $277.195 to $308.63 per share.
Tianci International, Inc. SC 13G/A neutral materiality 5/10

20-08-2026

S.H.N. Financial Investments Ltd. filed an amended Schedule 13G/A with the SEC on August 20, 2026, disclosing beneficial ownership of 127,928 warrants of Tianci International, Inc. (CIIT), representing 9.99% of the company's outstanding common stock (1,152,639 shares as of that date). The filing also notes an additional 176,484 warrants subject to the same 9.99% limitation, and that Nir Shamir, CEO of S.H.N. Financial Investments, may be deemed to beneficially own these securities.

  • · The amendment revises the percent of class based on post-split shares outstanding.
  • · The prior Schedule 13G/A was filed on August 14, 2026, covering 304,416 warrants purchased on June 16, 2026.
  • · The beneficial ownership limitation of 9.99% applies to both the 127,928 and the 176,484 warrants.
  • · Nir Shamir disclaims beneficial ownership of these securities for all other purposes beyond Rule 13d-3.
BlackSky Technology Inc. SC 13D/A neutral materiality 3/10

20-08-2026

Mithril LP and Mithril II LP filed Amendment No. 4 to their Schedule 13D for BlackSky Technology Inc., reporting pro rata distributions of shares to their partners on June 5, 2026. Mithril I distributed 1,298,328 shares of Common Stock, and Mithril II distributed 1,030,175 shares, both without additional consideration. The filing indicates a reduction in the reporting persons' direct holdings but no change in beneficial ownership structure.

  • · The filing is Amendment No. 4 to the original Schedule 13D filed on September 20, 2021.
  • · Previous amendments were filed on April 20, 2024, November 12, 2024, and August 11, 2025.
  • · The distributions were pro rata and without additional consideration.
  • · The reporting persons' aggregate beneficial ownership percentage is reported as 0.0% on the cover pages, indicating a complete distribution of their direct holdings.
Hepion Pharmaceuticals, Inc. SC 13D/A neutral materiality 7/10

20-08-2026

Vincent LoPriore, Executive Chairman of Hepion Pharmaceuticals, and affiliated entities Gravitas Capital LP and Invictus Capital Advisors Pension Plan filed a Schedule 13D/A disclosing aggregate beneficial ownership of 26,250,000 shares (26.2% of outstanding common stock) as of August 10, 2026. The filing details recent acquisitions totaling $750,000, including 10,000,000 shares and warrants for 10,000,000 shares at $0.06 per share, but notes no plans for any change in control or extraordinary corporate transactions.

  • · The filing is an amendment (SC 13D/A) filed on August 20, 2026.
  • · Vincent LoPriore is the Executive Chairman of Hepion Pharmaceuticals.
  • · Gravitas Capital LP is a Delaware limited partnership; Invictus Capital Advisors Pension Plan is organized under U.S. law.
  • · The warrants acquired on July 31, 2026 are immediately exercisable at $0.06 per share, subject to a beneficial ownership limitation.
  • · No transactions in the common stock were effected by the Reporting Persons during the past sixty days except those described.
  • · The Reporting Persons have no plans or proposals relating to any of the matters in Item 4 of Schedule 13D (e.g., change in control, extraordinary corporate transactions).
Hepion Pharmaceuticals, Inc. SC 13D neutral materiality 5/10

20-08-2026

Sireesh Appajosyula, a director and COO of Hepion Pharmaceuticals, filed a Schedule 13D disclosing beneficial ownership of 5,250,000 shares (5.7% of outstanding common stock), including 2,000,000 shares issuable upon exercise of warrants. The shares were acquired in two private placements in April and July 2026 for a total of $150,000, with the most recent purchase at $0.06 per share. The filing indicates no plans for a change in control or other extraordinary transactions.

  • · The warrant acquired on July 31, 2026 is immediately exercisable at $0.06 per share, subject to a beneficial ownership limitation.
  • · The reporting person acquired 1,250,000 shares on April 21, 2026 for $50,000 and 2,000,000 shares plus a warrant for 2,000,000 shares on July 31, 2026 for $100,000.
  • · No other transactions in common stock were effected by the reporting person in the past 60 days.
Hepion Pharmaceuticals, Inc. SC 13D neutral materiality 5/10

20-08-2026

Gary Stetz, a director and interim CEO of Hepion Pharmaceuticals, filed a Schedule 13D disclosing beneficial ownership of 5,250,000 shares of common stock (5.7% of outstanding shares) as of August 10, 2026. His holdings include 2,000,000 shares acquired on July 31, 2026, along with a warrant to purchase an additional 2,000,000 shares at $0.06 per share, for a total purchase price of $100,000. The filing indicates no plans for major corporate changes, and the total cost of his stake is approximately $150,000.

  • · Warrant exercise price is $0.06 per share, subject to a beneficial ownership limitation.
  • · Stetz acquired 1,250,000 shares on April 21, 2026 for $50,000, and 2,000,000 shares plus a warrant for 2,000,000 shares on July 31, 2026 for $100,000.
  • · No other transactions in the common stock were effected by the reporting person in the past 60 days.
Swarmer, Inc SC 13G neutral materiality 6/10

20-08-2026

RG.AI Technologies, Inc., Oedipus Inc., and Charles Eberly von Szecsey filed a Schedule 13G disclosing shared beneficial ownership of 1,309,331 shares of Swarmer, Inc common stock, representing a 10.98% stake as of August 10, 2026. The filing is late due to an inadvertent administrative oversight.

  • · The filing is late due to an inadvertent administrative oversight.
  • · Swarmer, Inc's common stock has a par value of $0.00001 per share.
  • · The outstanding share count of 11,922,750 is based on the issuer's Quarterly Report on Form 10-Q filed on August 14, 2026.
  • · All three reporting persons disclaim beneficial ownership except to the extent of their pecuniary interests.
Black Stone Minerals, L.P. SC 13G neutral materiality 5/10

20-08-2026

Morgan Stanley filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 11,022,504 common units of Black Stone Minerals, L.P., representing 5.2% of the outstanding limited partner interests. The filing was made under Rule 13d-1(c), indicating a passive investment intent, and Morgan Stanley disclaims any purpose of changing or influencing control of the issuer.

  • · Morgan Stanley reported sole voting power over 10,591,252 common units and sole dispositive power over 11,022,504 common units.
  • · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, confirming a passive investment intent.
  • · Morgan Stanley's address is 1585 Broadway, New York, NY 10036.
  • · The filing date is August 20, 2026, with the event triggering the filing occurring on August 6, 2026.
RE/MAX Holdings, Inc. SC 13G neutral materiality 5/10

20-08-2026

ExodusPoint Capital Management, LP and related entities disclosed beneficial ownership of 1,004,155 shares of RE/MAX Holdings, Inc. Class A Common Stock, representing approximately 4.7% of outstanding shares as of August 19, 2026. The filing is a Schedule 13G (passive investment) and indicates no intent to change or influence control of the issuer.

  • · The shares are held directly by ExodusPoint Partners Master Fund, LP, an investment fund managed by ExodusPoint Capital Management.
  • · ExodusPoint Capital Management, ExodusPoint Capital Partners GP, LLC, and Michael Gelband each disclaim beneficial ownership except to the extent of their pecuniary interest.
  • · The filing is made pursuant to Rule 13d-1(c) (passive investor exemption).
  • · The reporting persons certify that the securities were not acquired with the purpose or effect of changing or influencing control of the issuer.
CIMPRESS plc SC 13D/A neutral materiality 6/10

20-08-2026

Spruce House Investment Management LLC and related entities filed an amended Schedule 13D disclosing that as of August 18, 2026, they ceased to be beneficial owners of more than 5% of Cimpress plc's ordinary shares. The group now holds 1,022,633 shares (4.2% of outstanding shares) after selling 200,000 shares in open market transactions on August 18-19, 2026, at prices around $90.13-$90.32 per share. The filing also notes that Zachary Sternberg and Benjamin Stein each directly own small additional stakes, bringing their individual beneficial ownership to approximately 4.3%.

  • · The group's ownership dropped below 5% on August 18, 2026, triggering the filing.
  • · Sternberg holds 5,128 unvested performance stock units from his tenure as a former director, which are excluded from beneficial ownership calculations due to unmet performance conditions.
  • · Sternberg did not stand for re-election at the 2024 annual meeting and is no longer a director of Cimpress.
  • · The filing amends previous Schedule 13D filings from July 2025, December 2025, February 2026, and May 2026.
BiomX Inc. SC 13G/A neutral materiality 3/10

20-08-2026

The Cystic Fibrosis Foundation filed a Schedule 13G/A with the SEC on August 20, 2026, disclosing beneficial ownership of 174,276 shares of BiomX Inc. common stock, representing 1.47% of the outstanding shares. The filing indicates a minor decrease in both share count and percentage from the prior period (previously 176,476 shares and 1.5%), showing a slight reduction in the foundation's stake.

  • · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
  • · The Cystic Fibrosis Foundation certifies the shares were not acquired to change or influence control of BiomX Inc.
  • · The Cystic Fibrosis Foundation has sole voting and dispositive power over all 174,276 shares.
  • · BiomX Inc. is incorporated in Delaware with its business address in Ness Ziona, Israel.
Rank One Computing Corp dba ROC SC 13G neutral materiality 5/10

20-08-2026

Laurence W. Lytton filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 967,807 shares of Rank One Computing Corp (ROC) common stock, representing a 5.1% stake. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

  • · Filing type: Schedule 13G (passive investment, not 13D)
  • · Shares acquired on August 14, 2026
  • · Issuer's common stock CUSIP: 753040104
  • · Lytton's sole voting and dispositive power over all 967,807 shares
  • · Filing made under Rule 13d-1(c) (passive investor exemption)
Dogness (International) Corp SC 13D neutral materiality 8/10

20-08-2026

Fuxing Yang and his wholly-owned entity Ming Kai Trading International Limited filed a Schedule 13D disclosing beneficial ownership of 3,050,000 Class A common shares of Dogness (International) Corp, representing 35.67% of the outstanding shares. The shares were acquired through the exercise of warrants at a nominal price of $0.00001 per share (aggregate $30.50) as part of a revised acquisition agreement that reduced the target equity stake from 19.5% to 6.735% while keeping the consideration unchanged. The filing also notes that the warrants were amended to waive the beneficial ownership limitation and remove the 61-day waiting period, allowing full immediate exercise.

  • · The warrants were exercised directly with the issuer, not through open market transactions.
  • · The source of funds for the exercise price was the Reporting Person's working capital; no borrowed funds were used.
  • · The warrants were amended to waive the beneficial ownership limitation and remove the 61-day waiting period.
  • · The acquired shares are subject to a contractual lock-up ending nine months after Party A-1 is registered as holder of the 6.735% target equity.
  • · The Reporting Persons may acquire additional securities or dispose of securities in the future, subject to applicable law.
MAYFAIR GOLD CORP. SC 13G neutral materiality 3/10

20-08-2026

Oaktree Capital Management, L.P. and its affiliates filed a Schedule 13G with the SEC on August 20, 2026, disclosing aggregate beneficial ownership of 5,500,000 common shares of Mayfair Gold Corp., representing 8.19% of the 67,138,496 shares outstanding as of June 30, 2026. The filing includes 1,000,000 shares acquired on August 19, 2026, and is made jointly by Oaktree Value Opportunities Fund, L.P. (3,210,987 shares, 4.78%), Oaktree London Liquid Value Opportunities Fund (VOF), L.P. (1,400,707 shares, 2.09%), Oaktree Capital Management, L.P., and Oaktree Capital Holdings, LLC. The filing is a routine beneficial ownership disclosure under Rule 13d-1(d) and does not indicate any change in control or corporate action.

  • · The filing is made pursuant to Rule 13d-1(d) under the Securities Exchange Act of 1934.
  • · Oaktree Capital Holdings, LLC is the sole managing member of the general partner of Oaktree Capital Management, L.P.
  • · The filing includes a Joint Filing Agreement dated August 20, 2026, among the Reporting Persons.
  • · The issuer's common shares have no par value and are listed under CIK 0001823255.
Strata Critical Medical, Inc. SC 13G/A neutral materiality 5/10

20-08-2026

Steele ExpCo Holdings, LLC, KSL Capital Partners V GP, LLC, and Eric Charles Resnick filed Amendment No. 3 to their Schedule 13G, reporting beneficial ownership of 7,923,000 shares of Strata Critical Medical, Inc. Class A Common Stock, representing 9.0% of the outstanding shares as of June 30, 2026. On May 7, 2026, 4,500,000 warrants held by Steele ExpCo Holdings expired unexercised, reducing their potential economic exposure.

  • · The Schedule 13G was originally filed on February 12, 2020, and previously amended on January 24, 2022 and February 9, 2023.
  • · The filing is an amendment (No. 3) and does not modify any other items of the original Schedule 13G.
  • · The Reporting Persons' address is c/o Steele ExpCo Holdings, LLC, 100 St. Paul St., Suite 800, Denver, CO 80206.
  • · KSL Capital Partners V GP, LLC is the managing member of Steele ExpCo Holdings, LLC; Eric Charles Resnick is the managing member of KSL Capital Partners V GP, LLC.
  • · The percentage calculation is based on 88,466,806 shares outstanding as of July 28, 2026, per the Issuer's Form 10-Q filed August 4, 2026.
CHARTER COMMUNICATIONS, INC. /MO/ SC 13D/A neutral materiality 5/10

20-08-2026

Advance/Newhouse Partnership and related entities filed an amended Schedule 13D with the SEC on August 20, 2026, disclosing beneficial ownership of approximately 18.65 million shares of Charter Communications Class A Common Stock (including Class B Common Units on an as-converted basis), representing 14.35% of outstanding shares as of that date. The filing also reports the closing of the Cox Communications transaction on August 19, 2026, and the execution of several ancillary agreements, while noting that the share repurchase program with A/N remains suspended following a notice delivered in August 2025.

  • · The Schedule 13D/A was filed as Amendment No. 20, amending the original filing dated May 27, 2016.
  • · The Cox transaction closed on August 19, 2026, and A/N entered into five ancillary agreements in connection with it.
  • · A/N delivered a suspension notice on August 4, 2025, suspending the share repurchase program under the Share Repurchase Agreement, and intends for the suspension to continue after executing the A/N Letter Agreement.
  • · The Reporting Persons disclaim membership in a group with Liberty Broadband Corporation or Cox Parent.
  • · Michael A. Newhouse and Samuel I. Newhouse III are expressly disclaimed as being members of a group with the Reporting Persons.
Liberty Broadband Corp SC 13D/A neutral materiality 3/10

20-08-2026

Ronald A. Duncan filed a final Schedule 13D/A exit filing for Liberty Broadband Corp (now Fusion Merger Sub 1, LLC) on August 20, 2026, disclosing that he ceased to be a beneficial owner of more than 5% of the Series A Cumulative Redeemable Preferred Stock. This follows the completion of the merger with Charter Communications on August 19, 2026, in which all Preferred Stock was automatically converted into Charter preferred stock, leaving Duncan with zero shares. The filing marks the end of his reporting obligation as a major shareholder.

  • · The merger was originally announced on November 12, 2024, via an Agreement and Plan of Merger.
  • · Each share of Preferred Stock was automatically converted into one share of Charter's newly issued Series A cumulative redeemable preferred stock (par value $0.001 per share).
  • · Duncan has not been charged or convicted in any criminal proceeding in the last five years, nor been party to any adverse securities-related civil proceeding.
  • · Duncan's business address is 2550 Denali Street, Suite 1000, Anchorage, Alaska 99503.
CHARTER COMMUNICATIONS, INC. /MO/ SC 13G neutral materiality 5/10

20-08-2026

Ronald A. Duncan filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 474,976 shares of Charter Communications, Inc. Series A Cumulative Redeemable Preferred Stock, representing 6.6% of the 7,183,812 shares outstanding. The filing includes shares held directly and indirectly through entities and a foundation, with 396,400 shares pledged as collateral for margin loans. This passive investment filing indicates a significant but non-controlling stake.

  • · The filing is made under Rule 13d-1(c), indicating passive investment intent.
  • · Mr. Duncan disclaims beneficial ownership of 18,041 shares held by his wife, Dani Bowman.
  • · Ownership includes shares held through 560 Company, Inc. (55% owned by Mr. Duncan), Missy, LLC, and a foundation over which he has voting control.
  • · No transactions were reported; the filing reflects holdings as of August 19, 2026.
Brera Holdings PLC SC 13D/A neutral materiality 5/10

20-08-2026

Keren Kalima Maimon filed Amendment No. 2 to Schedule 13D, reporting that she and other former group members have each ceased to be beneficial owners of more than 5% of Brera Holdings PLC's Class B Ordinary Shares, and this is an exit filing. The amendment details transactions in the company's shares, including sales by Maimon and others, and the dissolution of the group. The filing also notes a 1-for-10 reverse share split effective April 7, 2026, which is not reflected in the share numbers.

  • · The filing is an exit filing; each reporting person has ceased to be a beneficial owner of more than 5% of the outstanding Class B Ordinary Shares.
  • · The Schedule 13D group was disbanded as of the Event Date (September 23, 2025).
  • · The share numbers do not reflect the 1-for-10 reverse share split effective April 7, 2026.
  • · Ms. Maimon's sales on 9/25/2025, 9/29/2025, and 9/30/2025 were at prices ranging from $23.65 to $35.05 per share.
  • · The Strategic Advisors received warrants in connection with their advisory roles.
Brera Holdings PLC SC 13D/A neutral materiality 3/10

20-08-2026

Alyazi Saeed Ahmad Alkhattal Almheiri filed Amendment No. 2 to Schedule 13D, reporting that the Schedule 13(d) group has disbanded and that each former group member now beneficially owns less than 5% of Brera Holdings PLC's outstanding Class B Ordinary Shares. The filing serves as an exit filing for all Reporting Persons, who cease to be Reporting Persons immediately upon filing. The amendment also details transactions in the company's shares by various individuals, including sales and purchases, and notes that share numbers do not reflect a 1-for-10 reverse share split that occurred on April 7, 2026.

  • · The Schedule 13(d) group was disbanded as of September 23, 2025 (Event Date).
  • · Each former group member now individually owns less than 5% of outstanding Ordinary Shares.
  • · Share numbers in the filing do not reflect the 1-for-10 reverse share split effective April 7, 2026.
  • · Ms. Maimon sold 44,444 Ordinary Shares and 44,444 warrants to Ms. Almheiri for $200,000, and the same to Mr. Alnuaimi for $200,000.
  • · Ms. Almheiri sold 4,285 Ordinary Shares at $34.90 per share on October 1, 2025.
ICL Group Ltd. SC 13G/A neutral materiality 5/10

20-08-2026

Phoenix Financial Ltd. filed a Schedule 13G/A with the SEC on August 20, 2026, disclosing beneficial ownership of 64,298,945.76 ordinary shares of ICL Group Ltd., representing 4.98% of the total outstanding shares as of August 13, 2026. The filing is an amendment to a prior Schedule 13G and reflects a slight decrease from the 5.0% threshold, as the ownership stake is now just below 5%. The shares are held through various Phoenix subsidiaries, each of which makes independent voting and investment decisions.

  • · The filing is an amendment to a prior Schedule 13G, indicating a change in ownership from a previous filing.
  • · The ownership is held through multiple subsidiaries: Phoenix Investments House - trust funds (18,412,088.76 shares / 1.43%), Partnership for Israeli shares (44,883,318 shares / 3.48%), Partnership for investing in shares indexes (148,166 shares / 0.01%), Phoenix pension and provident funds (284,619 shares / 0.02%), and Linked insurance policies of Phoenix (570,754 shares / 0.04%).
  • · The filing certifies that the securities were not acquired for the purpose of changing or influencing control of ICL Group Ltd.
ADDENTAX GROUP CORP. SC 13G neutral materiality 5/10

20-08-2026

Hong Zhihao disclosed a beneficial ownership of 250,000 shares of Addentax Group Corp. common stock via Schedule 13G filing on August 20, 2026, representing 11.88% of the total 2,105,058 shares outstanding as of August 19, 2026. The filing indicates the securities were not acquired for the purpose of changing or influencing control of the issuer. No prior period data is provided in the filing, so period-over-period comparisons are not available.

  • · The filing is made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
  • · Hong Zhihao has sole voting power and sole dispositive power over all 250,000 shares.
  • · Hong Zhihao's address is Room 4E, Fuya Garden, Fumin Road, Futian District, Shenzhen City, Guangdong, China.
ADDENTAX GROUP CORP. SC 13D neutral materiality 5/10

20-08-2026

Hong Zhiwang, a director of Addentax Group Corp., filed a Schedule 13D disclosing beneficial ownership of 225,174 shares of common stock, representing approximately 10.7% of the outstanding shares. This follows a private placement on August 18, 2026, in which the issuer issued 218,750 shares to the reporting person, increasing his prior stake from 6,424 shares. The filing indicates no current plans for major corporate actions, though the reporting person may engage in discussions regarding the issuer's business and operations.

  • · The private placement was made pursuant to a Private Placement Agreement dated July 30, 2026.
  • · Hong Zhiwang has sole voting and dispositive power over all 225,174 shares.
  • · The reporting person's principal occupation is serving as Director of Addentax Group Corp.
  • · No other person has the right to receive dividends or proceeds from the sale of the shares.
ADDENTAX GROUP CORP. SC 13D/A neutral materiality 3/10

20-08-2026

Or Shan Shan filed a Schedule 13D/A with the SEC on August 20, 2026, disclosing beneficial ownership of 137,790 shares of Addentax Group Corp. common stock, representing 6.55% of the outstanding shares. The filing indicates sole voting and dispositive power over all shares, with no change in the reported position from the prior filing.

  • · Or Shan Shan has sole voting power and sole dispositive power over all 137,790 shares.
  • · The filing is an amendment (Schedule 13D/A) to a previously filed Schedule 13D.
  • · The business address of Addentax Group Corp. is Kingkey 100, Block A, Room 4805, Luohu District, Shenzhen City, China.
  • · Or Shan Shan's address is Flat G7, Block E, Mount Pavilia, No. 663 Clear Water Bay Road, Hong Kong.
ADDENTAX GROUP CORP. SC 13G/A neutral materiality 3/10

20-08-2026

Seah Chia Yee filed a Schedule 13G/A with the SEC on August 20, 2026, disclosing beneficial ownership of 146,539 shares of Addentax Group Corp. common stock, representing 6.96% of the 2,105,058 shares outstanding as of August 19, 2026. The filing indicates no change in the number of shares held compared to the prior filing, and the shares were acquired in the ordinary course of business without the intent to influence control.

  • · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
  • · Seah Chia Yee's address is in Shah Alam, Malaysia.
  • · The shares were acquired under Rule 13d-1(c), indicating passive investment intent.
  • · No change in share count from the previous filing (0.00 shares difference).
ADDENTAX GROUP CORP. SC 13G neutral materiality 5/10

20-08-2026

Pinnacle Partners Inc. filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 250,000 shares of Addentax Group Corp. common stock, representing an 11.88% stake as of August 19, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence control of the issuer.

  • · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, confirming a passive investment intent.
  • · Pinnacle Partners Inc. is based in the British Virgin Islands (Tortola).
  • · Addentax Group Corp. is incorporated in Nevada and headquartered in Shenzhen, China, with a fiscal year ending March 31.
Athira Pharma, Inc. SC 13G/A neutral materiality 3/10

20-08-2026

Acorn Bioventures, L.P., Acorn Bioventures 2, L.P., and their affiliates (including Anders Hove) filed a Schedule 13G/A disclosing aggregate beneficial ownership of 1,492,521 shares of LeonaBio, Inc. (formerly Athira Pharma, Inc.) common stock, representing 12.1% of the 9,421,663 shares outstanding as of August 12, 2026. The filing is a routine update of holdings and does not indicate any change in control intent.

  • · The filing is an amendment (Schedule 13G/A) filed on August 20, 2026.
  • · The subject company changed its name from Athira Pharma, Inc. to LeonaBio, Inc. on September 16, 2019.
  • · All reporting persons certify that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.
KAMADA LTD SC 13G/A neutral materiality 5/10

20-08-2026

Phoenix Financial Ltd. filed a Schedule 13G/A with the SEC on August 20, 2026, disclosing beneficial ownership of 2,652,234.66 ordinary shares of Kamada Ltd., representing 4.6% of the 57,681,420 outstanding shares as of August 13, 2026. The filing is an amendment to a prior 13G and indicates a passive investment stake, with no intent to change or influence control of the company.

  • · The filing is an amendment to a prior Schedule 13G (initial filing referenced from February 7, 2022).
  • · Ownership is held through subsidiaries: 128,669.54 shares (0.22%) via trust funds, 2,420,788 shares (4.2%) via Partnership for Israeli shares, and 102,777.12 shares (0.18%) via Partnership for investing in shares indexes.
  • · The filing certifies that the securities were not acquired to change or influence control of the issuer.
  • · Phoenix Financial Ltd. is based in Givatayim, Israel, and was formerly known as Phoenix Holdings Ltd. (name changed July 13, 2016).
22nd Century Group, Inc. SC 13G neutral materiality 5/10

20-08-2026

Joseph Reda and SEG Opportunity Fund, LLC filed a Schedule 13G disclosing combined beneficial ownership of 71,256 shares of 22nd Century Group, Inc. common stock, representing approximately 9.97% of the 713,994 outstanding shares as of August 19, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with no control-related purpose.

  • · Joseph Reda is the manager of SEG Opportunity Fund, LLC and may be deemed to beneficially own SEG's shares.
  • · The filing is made pursuant to Rule 13d-1(c), indicating passive investment intent.
  • · The Reporting Persons disclaim membership in any group for Section 13(d) or 13(g) purposes.
  • · The filing includes a Joint Filing Agreement between Joseph Reda and SEG Opportunity Fund, LLC.
Elastic N.V. SC 13D/A neutral materiality 5/10

20-08-2026

Pictet Asset Management SA filed a Schedule 13D/A disclosing it holds 5,393,567 shares (5.18%) of Elastic N.V. as of August 19, 2026. The investment cost was approximately USD 400.8 million. While the fund states it does not seek control, it explicitly reserves the right to change its intentions and may seek to influence issuer policies through board and management engagement, introducing mild activist uncertainty.

  • · Pictet Asset Management SA has sole voting power over 5,377,364 of its 5,393,567 shares (99.7%).
  • · The reporting person has not been convicted in any criminal proceeding or been party to adverse civil securities-related proceedings in the last five years.
  • · Acquisition funds came from institutional clients' assets with no financing or borrowing involved.
  • · Pictet engages with issuers on long-term strategy, governance, financial strength, and sustainability risks, and may seek to influence policies through board/management discussions.
Advanced Biomed Inc. SC 13G/A negative materiality 5/10

20-08-2026

Pau Hung To filed a Schedule 13G/A with the SEC on August 20, 2026, reporting that he no longer holds any shares of Advanced Biomed Inc. common stock. The filing indicates that on July 27, 2026, he transferred 100,000 shares to Lu Yi and 76,225 shares to Zhao Jie in satisfaction of $480,000 in aggregate indebtedness, reducing his beneficial ownership to 0%.

  • · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c).
  • · Pau Hung To is a citizen of the People's Republic of China.
  • · The transfers occurred on July 27, 2026.
  • · The issuer's common stock has a par value of $0.001 per share.
  • · The filing certifies the securities were not acquired or held for changing or influencing control of the issuer.
Advanced Biomed Inc. SC 13G neutral materiality 4/10

20-08-2026

Pau Hung To filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 176,225 shares of Advanced Biomed Inc. (ADVB) common stock, representing a 12.75% stake. The shares were acquired in October 2022 via a debt-for-equity exchange and have been adjusted for subsequent stock splits. The filing indicates passive investment intent, not control.

  • · The 176,225 shares were originally issued as 4,405,625 shares on October 24, 2022, adjusted for a 4-for-1 forward split (May 2023), a 1-for-5 reverse split (October 2024), and a 1-for-20 reverse split (February 2026).
  • · The filing is made under Rule 13d-1(c), indicating passive investment intent.
  • · Pau Hung To is a citizen of the People's Republic of China and resides in Hong Kong.
22nd Century Group, Inc. SC 13G neutral materiality 5/10

20-08-2026

Jonathan Schechter filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 71,256 shares of 22nd Century Group, Inc. common stock, representing 9.9% of the 713,994 shares outstanding as of August 19, 2026. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

  • · The filing is made under Rule 13d-1(c), indicating the filer is not an affiliate of the issuer.
  • · Jonathan Schechter's address is 135 Sycamore Drive, Roslyn, NY 11576.
  • · The issuer's principal executive offices are at 321 Farmington Road, Mocksville, NC 27028.
  • · The shares have a par value of $0.00001 per share.
Thunder Bridge Capital Partners V, Ltd. SC 13G neutral materiality 3/10

20-08-2026

Linden Capital L.P. and related entities disclosed beneficial ownership of 1,950,000 Class A ordinary shares of Thunder Bridge Capital Partners V, Ltd., representing 6.3% of shares outstanding as of August 14, 2026. The filing is a Schedule 13G under Rule 13d-1(c), indicating passive investment intent. No period-over-period comparisons are available as this is an initial disclosure.

  • · The filing is made under Rule 13d-1(c), indicating the securities were not acquired with the purpose of changing or influencing control of the issuer.
  • · Linden GP LLC is the general partner of Linden Capital L.P.; Linden Advisors LP is the investment manager; Siu Min Wong is the principal owner and controlling person of both.
  • · The principal business address for Linden Capital is Victoria Place, 31 Victoria Street, Hamilton HM10, Bermuda.
  • · The principal business address for Linden Advisors, Linden GP, and Mr. Wong is 590 Madison Avenue, 32nd Floor, New York, New York 10022.
  • · Mr. Wong is a citizen of China (Hong Kong) and the United States.
GMR Solutions Inc. SC 13G neutral materiality 5/10

20-08-2026

North Peak Capital Management, LLC and related entities filed a Schedule 13G on August 20, 2026, disclosing beneficial ownership of 3,375,609 shares of GMR Solutions Inc. Class A common stock, representing 6.2% of the 54,021,711 shares outstanding as of August 10, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), with the reporting persons certifying the shares were not acquired to influence control of the issuer.

  • · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
  • · North Peak Capital Management, LLC serves as investment manager for the funds and as investment adviser to a separately managed account (823,648 shares) over which it has no voting authority.
  • · North Peak Capital GP, LLC is the general partner of Fund I, Fund II, Alpha Fund, and Ultra Fund.
  • · Each reporting person disclaims beneficial ownership of shares held by other reporting persons.
  • · The joint filing agreement was executed on August 20, 2026.
MARRIOTT VACATIONS WORLDWIDE Corp SC 13D/A neutral materiality 5/10

20-08-2026

Impactive Capital LP and related parties filed Amendment No. 4 to their Schedule 13D, disclosing a 9.8% beneficial ownership stake in Marriott Vacations Worldwide Corp. The amendment reports a sale of 750,000 shares on August 19, 2026, at $111.49 per share, which was undertaken for portfolio rebalancing and not indicative of a negative view on the company's prospects. The filing also updates the aggregate ownership percentage based on 34,395,320 shares outstanding as of July 30, 2026.

  • · The sale of 750,000 shares represents approximately 2.2% of the shares outstanding.
  • · The filing is Amendment No. 4 to the original Schedule 13D filed on April 19, 2024.
  • · The reporting persons include Impactive Capital LP, Impactive Capital LLC, Lauren Taylor Wolfe, and Christian Asmar, each with shared voting and dispositive power over the shares.
  • · The sale was conducted in the open market through brokers, with the price per share excluding commissions.
GoPro, Inc. SC 13G neutral materiality 6/10

20-08-2026

Mark Edward Fischbach filed a Schedule 13G with the SEC on August 20, 2026, disclosing beneficial ownership of 13,500,000 shares of GoPro, Inc. Class A Common Stock, representing an 8.5% stake. The filing indicates the shares were acquired on July 13, 2026, and are held for investment purposes without intent to change or influence control of the company.

  • · The filing was made under Rule 13d-1(c), indicating a passive investment intent.
  • · Fischbach's sole voting and dispositive power covers all 13,500,000 shares.
  • · The filing date is August 20, 2026, with the acquisition date of July 13, 2026.
US ENERGY CORP SC 13D/A neutral materiality 3/10

20-08-2026

Joshua L. Batchelor, Benjamin A. Stamets, and related entities (Sage Road Capital, LLC, Banner Oil & Gas, LLC, Woodford Petroleum, LLC, Sage Road Energy II, LP, and SRC Management Company, LP) filed a Schedule 13D/A with the SEC on August 20, 2026, disclosing that they collectively beneficially own 2,580,751 shares of Big Sky Industrial Inc. (formerly US Energy Corp) common stock, representing 4.9% of the 52,493,428 shares outstanding as of August 4, 2026. This filing is the final amendment, as the reporting persons now each beneficially own less than 5% of the common stock, and they do not intend to file further amendments.

  • · This is Amendment No. 2 to the Schedule 13D, and it is the final amendment; no further amendments are intended.
  • · The reporting persons each beneficially own less than 5% of the common stock.
  • · The filing date is August 20, 2026, and the event triggering the filing occurred on August 11, 2026.
  • · The issuer's principal executive offices are at 1616 S. Voss, Suite 725, Houston, TX 77057.
CATO CORP SC 13G/A neutral materiality 3/10

20-08-2026

Amit Agarwal filed a Schedule 13G/A with the SEC on August 20, 2026, disclosing beneficial ownership of 690,000 shares of Cato Corp. Class A Common Stock, representing a 3.79% stake. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the company.

  • · The filing is an amendment (SCHEDULE 13G/A) to a previous beneficial ownership report.
  • · The filing was made under Rule 13d-1(c), indicating the investor is a passive investor.
  • · Amit Agarwal's address is listed as PO Box 18861, Tampa, FL 33679.
  • · The filing date is August 20, 2026, with a date of change of July 17, 2026.

Get daily alerts with 11 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 48 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Activist Hedge Fund Institutional SEC 13D 13G

🇺🇸 More from United States

View all →